Loading...

Qilian International Holding Group Limited

QLINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.41
$-0.20(-3.57%)

Qilian International Holding Group Limited QLI Peers

See (QLI) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
QLI$5.41-3.57%38.7M-4.92-$1.10N/A
ZTS$151.19+2.59%67.3B27.14$5.57+1.28%
TAK$14.55+0.76%46B63.30$0.23+4.05%
HLN$9.65+1.26%43.8B22.96$0.42+1.75%
TEVA$16.29-0.12%18.7B-14.15-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$132.75+0.70%13.1B45.00$2.95N/A
RDY$14.41-0.96%12B18.25$0.79+0.66%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$9.24+3.82%10.8B-2.91-$3.18+5.21%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

QLI vs ZTS Comparison

QLI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QLI stands at 38.7M. In comparison, ZTS has a market cap of 67.3B. Regarding current trading prices, QLI is priced at $5.41, while ZTS trades at $151.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QLI currently has a P/E ratio of -4.92, whereas ZTS's P/E ratio is 27.14. In terms of profitability, QLI's ROE is -0.16%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, QLI is less volatile compared to ZTS. This indicates potentially lower risk in terms of short-term price fluctuations for QLI.

Stock Price Comparison

Loading...

Frequently Asked Questions

;